Fund Holdings — Krensavage Asset Management, LLC

Total Portfolio Value
$255.7K
Total Bought
$36.1K
Total Sold
$60.3K
Net Transaction
-$24.2K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
INDIVIOR PHARMACEUTICALS INC(INDV)0339,532+339,5320104.05%+10
EMBECTA CORP(EMBC)0735,340+735,340072.54%+7
UNITED THERAPEUTICS CORP(UTHR)91,28284,282-7,000445019.55%+6
ULTRAGENYX PHARMACEUTICAL IN(RARE)149,634390,879+241,245383.20%+5
JAZZ PHARMACEUTICALS PLC(JAZZ)167,816167,8160293212.41%+3
ARDELYX INC0500,000+500,000031.17%+3
BIOGEN INC(BIIB)10,00020,000+10,000241.43%+2
INMODE LTD(INMD)0120,942+120,942020.65%+2
ALKERMES PLC(ALKS)107,822107,8220341.49%+1
GSK PLC-SPON ADR(GSK)96,72996,7290552.09%+1
ABBOTT LABORATORIES05,000+5,000010.20%+1
REGENERON PHARMACEUTICALS(REGN)4,0004,0000331.21%0
EVOLUS INC(EOLS)100,000157,985+57,985110.25%-0
SANOFI-ADR(SNY)323,946323,946016166.10%-0
SUPERNUS PHARMACEUTICALS INC(SUPN)313,499280,681-32,81816155.67%-1
BIOMARIN PHARMACEUTICAL INC(BMRN)524,786524,7860313011.59%-2
VANDA PHARMACEUTICALS INC(VNDA)1,180,3881,180,38801083.19%-2
EXELIXIS INC(EXEL)493,526415,693-77,83322186.97%-4
BIONTECH SE-ADR(BNTX)99,52359,523-40,000952.07%-4
ENANTA PHARMACEUTICALS INC(ENTA)2,766,3902,866,138+99,748443614.16%-7
INDIVIOR PLC339,5320-339,532120—-12
CARDINAL HEALTH INC(CAH)73,7450-73,745150—-15
AVADEL PHARMACEUTICALS855,8600-855,860180—-18
Page 1 of 1
Krensavage Asset Management, LLC — 13F Holdings — Q1 2026 | TickerTrail